Phase I study of mRNA 1440

Trial Profile

Phase I study of mRNA 1440

Phase of Trial: Phase I

Latest Information Update: 04 Apr 2016

At a glance

  • Drugs MRNA 1440 (Primary)
  • Indications Infections
  • Focus Adverse reactions
  • Sponsors Moderna Therapeutics
  • Most Recent Events

    • 04 Apr 2016 According to a Moderna Therapeutics media release, the company announced in January that this Phase I study was underway in Europe for mRNA 1440, an infectious disease vaccine in development for an undisclosed target and indication.
    • 15 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top